Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Atlanta, GA
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Macon, GA
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Skokie, IL
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
West Dundee, IL
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
West Dundee, IL
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Evansville, IN
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Saint Louis, MO
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Forest Hills, NY
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Chapel Hill, NC
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
High Point, NC
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Winston-Salem, NC
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Hershey, PA
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Rapid City, SD
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Arlington, TX
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated:  4/18/2014
Clinical Research Facility
mi
from
Norfolk, VA
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
A Phase IIa Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Status: Enrolling
Updated: 4/18/2014
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Denver, CO
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Chicago, IL
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
New York, NY
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Portland, OR
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  4/23/2014
Clinical Research Facility
mi
from
Dallas, TX
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
A Phase Ib Randomized, Double-Blinded, Placebo-Controlled Multiple Rising Dose Clinical Trial to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MK-8226 in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 4/23/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated:  4/24/2014
Pfizer Investigational Site
mi
from
Fremont, CA
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated: 4/24/2014
Pfizer Investigational Site
mi
from
Fremont, CA
Click here to add this to my saved trials
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated:  4/24/2014
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated: 4/24/2014
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated:  4/24/2014
Pfizer Investigational Site
mi
from
Rochester, NY
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated: 4/24/2014
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated:  4/24/2014
Pfizer Investigational Site
mi
from
Stony Brook, NY
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated: 4/24/2014
Pfizer Investigational Site
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated:  4/24/2014
Pfizer Investigational Site
mi
from
Houston, TX
Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris
A Phase 2a Randomized, Double-blind, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Effects Of PF-05175157 On Moderate To Severe Acne Vulgaris In Adult Subjects
Status: Enrolling
Updated: 4/24/2014
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Vytorin in the Treatment of Alopecia Areata
A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata
Status: Enrolling
Updated:  7/30/2014
University of Miami
mi
from
Miami, FL
Vytorin in the Treatment of Alopecia Areata
A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata
Status: Enrolling
Updated: 7/30/2014
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Chicago, IL
Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
New York (2 locations), NY
Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
New York (2 locations), NY
Click here to add this to my saved trials
Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Dallas, TX
Study to Determine the Safety and Effectiveness of Dupilumab (REGN668/SAR231893) for Treatment of Atopic Dermatitis (AD)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  9/3/2014
Clinical Research Facility
mi
from
College Station, TX
Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 9/3/2014
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis
Pivotal Trials: Evaluation of a Rapid Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in the United States
Status: Enrolling
Updated:  9/5/2014
Mount Sinai School of Medicine
mi
from
New York, NY
Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis
Pivotal Trials: Evaluation of a Rapid Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in the United States
Status: Enrolling
Updated: 9/5/2014
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated:  9/22/2014
Rady Children's Hospital
mi
from
San Diego, CA
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated: 9/22/2014
Rady Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated:  9/22/2014
Anschutz Health and Wellness Center, University of Colorado
mi
from
Aurora, CO
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated: 9/22/2014
Anschutz Health and Wellness Center, University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated:  9/22/2014
Dermatology Specialists
mi
from
Louisville, KY
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated: 9/22/2014
Dermatology Specialists
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated:  9/22/2014
Oregon Health and Science University
mi
from
Portland, OR
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)
Status: Enrolling
Updated: 9/22/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema
Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema
Status: Enrolling
Updated:  10/9/2014
Univ of Minnesota
mi
from
Minneapolis, MN
Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema
Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema
Status: Enrolling
Updated: 10/9/2014
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
A Randomized, Double-Blind, Active Control, 5 Week Study to Evaluate the Safety and Skin Effects of A New, Twice-daily, Topically Applied Amino Acid Moisturizing Cream vs. Desonide Cream in Adult Atopic Dermatitis
Status: Enrolling
Updated:  11/10/2014
Mass General Hospital Clinical Unit for Research Trials in Skin
mi
from
Boston, MA
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
A Randomized, Double-Blind, Active Control, 5 Week Study to Evaluate the Safety and Skin Effects of A New, Twice-daily, Topically Applied Amino Acid Moisturizing Cream vs. Desonide Cream in Adult Atopic Dermatitis
Status: Enrolling
Updated: 11/10/2014
Mass General Hospital Clinical Unit for Research Trials in Skin
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  11/13/2014
DermResearch, Inc.
mi
from
Austin, TX
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 11/13/2014
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  11/13/2014
J&S Studies
mi
from
College Station, TX
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 11/13/2014
J&S Studies
mi
from
College Station, TX
Click here to add this to my saved trials
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated:  11/13/2014
Premier Clinical Research
mi
from
Spokane, WA
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
A Randomized, Single-Blind, Phase 2 Study to Determine the Safety, Tolerability, and Systemic Exposure of 3 Dose Regimens of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
Status: Enrolling
Updated: 11/13/2014
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated:  1/14/2015
Clinical Research Facility
mi
from
College Station, TX
Safety and Efficacy of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated: 1/14/2015
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
Neurobiology of the Scalp in Seborrheic Dermatitis
Neurobiology of the Scalp in Seborrheic Dermatitis
Status: Enrolling
Updated:  1/28/2015
Boston University
mi
from
Boston, MA
Neurobiology of the Scalp in Seborrheic Dermatitis
Neurobiology of the Scalp in Seborrheic Dermatitis
Status: Enrolling
Updated: 1/28/2015
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
Status: Enrolling
Updated:  4/16/2015
DermResearch, Inc.
mi
from
Austin, TX
To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
Status: Enrolling
Updated: 4/16/2015
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
Status: Enrolling
Updated:  6/1/2015
Academic Dermatology Associates
mi
from
Albuquerque, NM
To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis
Status: Enrolling
Updated: 6/1/2015
Academic Dermatology Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Status: Enrolling
Updated:  6/3/2015
RWJUH Dermatology office
mi
from
Somerset, NJ
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Status: Enrolling
Updated: 6/3/2015
RWJUH Dermatology office
mi
from
Somerset, NJ
Click here to add this to my saved trials
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Status: Enrolling
Updated:  6/22/2015
Akron Dermatology
mi
from
Akron, OH
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Status: Enrolling
Updated: 6/22/2015
Akron Dermatology
mi
from
Akron, OH
Click here to add this to my saved trials
Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Safety and Efficacy of Escalating Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days When Used on Full Face, Full Balding Scalp or Approximately 250 cm2 on the Chest in Subjects With Actinic Keratosis
Status: Enrolling
Updated:  7/2/2015
Laser & Skin Surgery Center of Inidana
mi
from
Carmel, IN
Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Safety and Efficacy of Escalating Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days When Used on Full Face, Full Balding Scalp or Approximately 250 cm2 on the Chest in Subjects With Actinic Keratosis
Status: Enrolling
Updated: 7/2/2015
Laser & Skin Surgery Center of Inidana
mi
from
Carmel, IN
Click here to add this to my saved trials
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
An Investigator-Initiated Study: Treatment of Staphylococcus Aureus Colonization in Hand Eczema Decreases Severity of Disease
Status: Enrolling
Updated:  7/8/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
An Investigator-Initiated Study: Treatment of Staphylococcus Aureus Colonization in Hand Eczema Decreases Severity of Disease
Status: Enrolling
Updated: 7/8/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials